CLDX Kronos AI forecast
A 30-trading-day price forecast for Celldex Therapeutics Inc. (CLDX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Celldex Therapeutics Inc. at $33.18 on 2026-12-08, +10.0% from the last close of $30.15 on 2026-10-27. Eight out of ten sampled paths end between $31.07 and $34.27, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of CLDX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $30.27 | $29.70 | $31.34 |
| 2026-11-10 | $30.64 | $29.80 | $30.95 |
| 2026-11-17 | $31.41 | $30.84 | $32.25 |
| 2026-11-24 | $32.33 | $31.39 | $32.88 |
| 2026-12-01 | $32.47 | $31.31 | $34.10 |
| 2026-12-08 | $33.18 | $31.07 | $34.27 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for CLDX?
- Kronos AI's median forecast for CLDX is $33.18 in 30 trading days, +10.0% from the last close, with a 10–90% range of $31.07 to $34.27.
- Is the CLDX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- IDXX — IDEXX Laboratories Inc.
- LNTH — Lantheus Holdings Inc.
- ORKA — Oruka Therapeutics Inc.
- NEOG — Neogen Corporation
- NTLA — Intellia Therapeutics Inc.
- QDEL — QuidelOrtho Corporation